Related references
Note: Only part of the references are listed.Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators
Anthony L. Gotter et al.
BMC NEUROSCIENCE (2014)
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
C. J. Winrow et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
Anthony L. Gotter et al.
BMC NEUROSCIENCE (2013)
Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats
Steven V. Fox et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Orexin receptor antagonism for treatment of insomnia A randomized clinical trial of suvorexant
W. Joseph Herring et al.
NEUROLOGY (2012)
Pharmacological characterization of MK-6096-A dual orexin receptor antagonist for insomnia
Christopher J. Winrow et al.
NEUROPHARMACOLOGY (2012)
Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational Insomnia
Paolo Bettica et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Orexin Receptors: Pharmacology and Therapeutic Opportunities
Thomas E. Scammell et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the America Insomnia Survey
Thomas Roth et al.
BIOLOGICAL PSYCHIATRY (2011)
Promotion of Sleep by Suvorexant--A Novel Dual Orexin Receptor Antagonist
Christopher J. Winrow et al.
JOURNAL OF NEUROGENETICS (2011)
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
S. J. Wilson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant
Hendrik Dietrich et al.
PSYCHOPHARMACOLOGY (2010)
Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers
S. Otmani et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Catherine Brisbare-Roch et al.
NATURE MEDICINE (2007)
Environmental noise, sleep and health
Alain Muzet
SLEEP MEDICINE REVIEWS (2007)
A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers
Ian Hindmarch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Hypothalamic regulation of sleep and circadian rhythms
CB Saper et al.
NATURE (2005)
Development of a body condition scoring system for nonhuman primates using Macaca mulatta as a model
KJ Clingerman et al.
LAB ANIMAL (2005)
Diagnosis and treatment of chronic insomnia: A review
RM Benca
PSYCHIATRIC SERVICES (2005)
The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents
DJ Sanger
CNS DRUGS (2004)
Cognitive effects of long-term benzodiazepine use - A meta-analysis
MJ Barker et al.
CNS DRUGS (2004)
Share Paper
